308 related articles for article (PubMed ID: 23140648)
61. Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy.
Siskind D; Sidhu A; Cross J; Chua YT; Myles N; Cohen D; Kisely S
Aust N Z J Psychiatry; 2020 May; 54(5):467-481. PubMed ID: 31957459
[TBL] [Abstract][Full Text] [Related]
62. Incidence and Management of Clozapine-Induced Myocarditis in a Large Tertiary Hospital.
Higgins JM; San C; Lagnado G; Chua D; Mihic T
Can J Psychiatry; 2019 Aug; 64(8):561-567. PubMed ID: 30599763
[TBL] [Abstract][Full Text] [Related]
63. The prevalence of agranulocytosis and related death in clozapine-treated patients: a comprehensive meta-analysis of observational studies.
Li XH; Zhong XM; Lu L; Zheng W; Wang SB; Rao WW; Wang S; Ng CH; Ungvari GS; Wang G; Xiang YT
Psychol Med; 2020 Mar; 50(4):583-594. PubMed ID: 30857568
[TBL] [Abstract][Full Text] [Related]
64. Clozapine and incidence of myocarditis and sudden death - Long term Australian experience.
Khan AA; Ashraf A; Baker D; Al-Omary MS; Savage L; Ekmejian A; Singh RSH; Brienesse S; Majeed T; Gordon T; Drinkwater V; Collins NJ
Int J Cardiol; 2017 Jul; 238():136-139. PubMed ID: 28343762
[TBL] [Abstract][Full Text] [Related]
65. Rapid-onset agranulocytosis in a patient treated with clozapine and lamotrigine.
Urban AE; Wiglusz MS; Cubała WJ; Landowski J; Krysta K
Psychiatr Danub; 2015 Sep; 27 Suppl 1():S459-61. PubMed ID: 26417816
[TBL] [Abstract][Full Text] [Related]
66. Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.
Blackman G; Kapila A; Grosskopf CM; Dratcu L
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):18-19. PubMed ID: 31910056
[No Abstract] [Full Text] [Related]
67. Clozapine in the treatment of refractory schizophrenia: a practical guide for healthcare professionals.
Flanagan RJ; Lally J; Gee S; Lyon R; Every-Palmer S
Br Med Bull; 2020 Oct; 135(1):73-89. PubMed ID: 32885238
[TBL] [Abstract][Full Text] [Related]
68. Clozapine-induced myocarditis, a widely overlooked adverse reaction.
Ronaldson KJ; Fitzgerald PB; McNeil JJ
Acta Psychiatr Scand; 2015 Oct; 132(4):231-40. PubMed ID: 25865238
[TBL] [Abstract][Full Text] [Related]
69. Guide to the Management of Clozapine-Related Tolerability and Safety Concerns.
Citrome L; McEvoy JP; Saklad SR
Clin Schizophr Relat Psychoses; 2016; 10(3):163-177. PubMed ID: 27732102
[TBL] [Abstract][Full Text] [Related]
70. Where to position clozapine: re-examining the evidence.
Agid O; Foussias G; Singh S; Remington G
Can J Psychiatry; 2010 Oct; 55(10):677-84. PubMed ID: 20964947
[TBL] [Abstract][Full Text] [Related]
71. Clozapine-related myocarditis and cardiomyopathy in an Australian metropolitan psychiatric service.
Reinders J; Parsonage W; Lange D; Potter JM; Plever S
Aust N Z J Psychiatry; 2004; 38(11-12):915-22. PubMed ID: 15555025
[TBL] [Abstract][Full Text] [Related]
72. Recognition and management of clozapine adverse effects: A systematic review and qualitative synthesis.
Gurrera RJ; Gearin PF; Love J; Li KJ; Xu A; Donaghey FH; Gerace MR
Acta Psychiatr Scand; 2022 May; 145(5):423-441. PubMed ID: 35178700
[TBL] [Abstract][Full Text] [Related]
73. Can Slow Personalized Titration Using C-Reactive Protein Monitoring Decrease the High Rates and Mortality of Clozapine-Associated Myocarditis Seen in Some Countries? A Call for Research.
de Leon J
J Clin Psychopharmacol; 2024 May-Jun 01; 44(3):212-219. PubMed ID: 38595145
[TBL] [Abstract][Full Text] [Related]
74. Clozapine-Associated Leukopenia and Agranulocytosis in Western Cape, South Africa: A 3-Year Retrospective Cohort Study.
Geldenhuys C; Zunza M; Tiffin N; Koen L; Decloedt EH
J Clin Psychopharmacol; 2021 May-Jun 01; 41(3):250-254. PubMed ID: 33843819
[TBL] [Abstract][Full Text] [Related]
75. Agranulocytosis during treatment with chlozapine.
Idänpään-Heikkilä J; Alhava E; Olkinuora M; Palva IP
Eur J Clin Pharmacol; 1977 Mar; 11(3):193-8. PubMed ID: 856603
[TBL] [Abstract][Full Text] [Related]
76. Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.
Girardin FR; Poncet A; Perrier A; Vernaz N; Pletscher M; F Samer C; Lieberman JA; Villard J
Pharmacogenomics J; 2019 Apr; 19(2):211-218. PubMed ID: 29298994
[TBL] [Abstract][Full Text] [Related]
77. Clinical course and analysis of ten fatal cases of clozapine-induced myocarditis and comparison with 66 surviving cases.
Ronaldson KJ; Fitzgerald PB; Taylor AJ; Topliss DJ; McNeil JJ
Schizophr Res; 2011 May; 128(1-3):161-5. PubMed ID: 21320766
[TBL] [Abstract][Full Text] [Related]
78. Characterization of Admission Types in Medically Hospitalized Patients Prescribed Clozapine.
Leung JG; Hasassri ME; Barreto JN; Nelson S; Morgan RJ
Psychosomatics; 2017; 58(2):164-172. PubMed ID: 28153339
[TBL] [Abstract][Full Text] [Related]
79. Hepatic venous outflow block caused by compressive fecaloma in a schizophrenic patient treated with clozapine.
Osseis M; Lim C; Lahat E; Doussot A; Salloum C; Azoulay D
Drug Discov Ther; 2015 Dec; 9(6):422-3. PubMed ID: 26781928
[TBL] [Abstract][Full Text] [Related]
80. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.
Palmer SE; McLean RM; Ellis PM; Harrison-Woolrych M
J Clin Psychiatry; 2008 May; 69(5):759-68. PubMed ID: 18452342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
